Visual orienting in schizophrenia.

Abstract:

:Patients with schizophrenia demonstrate a variety of attentional impairments which have proven difficult to relate to specific neural systems. Posner et al. (1988) reported an asymmetric slowing of right visual field orienting in schizophrenia similar to that observed in patients with parietal lesions. We examined the visual orienting performance of 19 patients and controls using two different versions of the Posner paradigm. In overall ANOVAs we found main effects of group, cue condition, and delay interval. However, we did not observe any main effect of visual field or interactions involving visual field. There was some evidence of an asymmetric cost of invalid cues similar to those reported by Posner et al. The bulk of data suggests bilateral attentional deficits.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Gold JM,Randolph C,Coppola R,Carpenter CJ,Goldberg TE,Weinberger DR

doi

10.1016/0920-9964(92)90013-u

subject

Has Abstract

pub_date

1992-09-01 00:00:00

pages

203-9

issue

3

eissn

0920-9964

issn

1573-2509

pii

0920-9964(92)90013-U

journal_volume

7

pub_type

杂志文章
  • Somatosensory evoked potentials during a rubber-hand illusion in schizophrenia.

    abstract::The rubber-hand illusion (RHI), an illusion in which tactile sensations are referred to a synthetic alien limb, is enhanced in schizophrenia patients. Somatosensory evoked responses of the illusion were compared between schizophrenia patients and normal control subjects. Schizophrenia patients had significant alterati...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(03)00057-4

    authors: Peled A,Pressman A,Geva AB,Modai I

    更新日期:2003-11-15 00:00:00

  • Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.

    abstract::Recent trials support the hypothesis of the role of inflammation in the pathogenesis of schizophrenia. The overall therapeutic benefit of anti-inflammatory medication, in particular cyclo-oxygenase-2 (COX-2) inhibitors in schizophrenia, is still controversial. There are suggestions that therapy with COX-2 inhibitors m...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2010.04.015

    authors: Müller N,Krause D,Dehning S,Musil R,Schennach-Wolff R,Obermeier M,Möller HJ,Klauss V,Schwarz MJ,Riedel M

    更新日期:2010-08-01 00:00:00

  • Brief executive function training for individuals with severe mental illness: Effects on EEG synchronization and executive functioning.

    abstract:BACKGROUND:Executive Functioning (EF) is an important factor for community functioning for people with severe mental illness. Cognitive remediation programs often improve EF, but do so by using multiple therapeutic techniques. Little is known regarding how individual treatment elements promote cognitive improvement. Os...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2017.08.052

    authors: Best MW,Gale D,Tran T,Haque MK,Bowie CR

    更新日期:2019-01-01 00:00:00

  • Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats.

    abstract::Astrocytic markers glial fibrillary acidic protein (GFAP) and connexin 43 (CX43) are known to have altered expression in brains of subjects with psychiatric disorders including autism and major depression. The current study investigated whether GFAP and CX43 expressions are affected by several commonly used psychotrop...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.05.016

    authors: Fatemi SH,Folsom TD,Reutiman TJ,Pandian T,Braun NN,Haug K

    更新日期:2008-09-01 00:00:00

  • Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.

    abstract::Comorbid substance abuse disorders have emerged as one of the greatest obstacles to the effective treatment of persons with schizophrenia. Estimates of the prevalence of such comorbidity vary, but as many as half of persons with schizophrenia may suffer from a comorbid drug or alcohol disorder. Younger age, male gende...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/s0920-9964(98)00161-3

    authors: Dixon L

    更新日期:1999-03-01 00:00:00

  • BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.

    abstract:BACKGROUND:Evidence indicating that symptoms of non-clinical psychosis (NCP) occur in 6-8% of the general population suggests that psychosis may occur across a continuum. Although a number of studies have examined environmental contributors, to date there have been few investigations of biological/genetic factors in th...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.06.018

    authors: Mittal VA,Smolen A,Dean DJ,Pelletier AL,Lunsford-Avery J,Smith A

    更新日期:2012-09-01 00:00:00

  • Individualized prediction of psychosis in subjects with an at-risk mental state.

    abstract::Early intervention strategies in psychosis would significantly benefit from the identification of reliable prognostic biomarkers. Pattern classification methods have shown the feasibility of an early diagnosis of psychosis onset both in clinical and familial high-risk populations. Here we were interested in replicatin...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.08.061

    authors: Zarogianni E,Storkey AJ,Borgwardt S,Smieskova R,Studerus E,Riecher-Rössler A,Lawrie SM

    更新日期:2019-12-01 00:00:00

  • Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial.

    abstract:BACKGROUND:Individuals at ultra-high risk (UHR) for psychosis have significant cognitive deficits that can impede functional recovery. Applying cognitive remediation (CR) before the onset of frank psychosis may improve the cognitive and functional prognosis of UHR individuals, however, little is known about the feasibi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2020.08.016

    authors: Glenthøj LB,Mariegaard LS,Fagerlund B,Jepsen JRM,Kristensen TD,Wenneberg C,Krakauer K,Medalia A,Roberts DL,Hjorthøj C,Nordentoft M

    更新日期:2020-10-01 00:00:00

  • Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.

    abstract:OBJECTIVE:The main goal of the present study was to analyze levels of cytokines of the interleukin family (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8 and IL-10), interferon-gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP1), tumor necrosis factor-alpha (TNF-α), and vascular endothelial and endothelial growth factors (V...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.08.027

    authors: Haring L,Koido K,Vasar V,Leping V,Zilmer K,Zilmer M,Vasar E

    更新日期:2015-12-01 00:00:00

  • Sex-specific rates of transmission of psychosis in the New England high-risk family study.

    abstract::Recent molecular genetic studies have demonstrated X-chromosome abnormalities in the transmission of psychosis, a finding that may contribute to understanding sex differences in the disorder. Using our family high risk paradigm, we tested the hypothesis that there are sex-specific patterns of transmission of psychosis...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.01.019

    authors: Goldstein JM,Cherkerzian S,Seidman LJ,Petryshen TL,Fitzmaurice G,Tsuang MT,Buka SL

    更新日期:2011-05-01 00:00:00

  • Cortical thinning and caudate abnormalities in first episode psychosis and their association with clinical outcome.

    abstract::First episode psychosis (FEP) has been associated with structural brain changes, largely identified by volumetric analyses. Advances in neuroimaging processing have made it possible to measure geometric properties that may identify subtle structural changes not appreciated by a measure of volume alone. In this study w...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.07.030

    authors: Scanlon C,Anderson-Schmidt H,Kilmartin L,McInerney S,Kenney J,McFarland J,Waldron M,Ambati S,Fullard A,Logan S,Hallahan B,Barker GJ,Elliott MA,McCarthy P,Cannon DM,McDonald C

    更新日期:2014-10-01 00:00:00

  • Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder.

    abstract:BACKGROUND:Stress has been associated with the onset of schizophrenia and exacerbation of psychotic symptoms. Patients with schizotypal personality disorder (SPD), the prototypic schizophrenia spectrum disorder, do not develop the frank psychosis of schizophrenia and appear clinically to be less reactive to stress than...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.schres.2003.10.008

    authors: Mitropoulou V,Goodman M,Sevy S,Elman I,New AS,Iskander EG,Silverman JM,Breier A,Siever LJ

    更新日期:2004-09-01 00:00:00

  • Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort.

    abstract::Little is known about the impact of family history of psychosis on youth from community samples. To fill this gap, we compared youth with a first-degree relative with psychosis spectrum symptoms (i.e. family history of psychosis spectrum symptoms, FHPS) to youth without FHPS in a cross-sectional analysis of the Philad...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.12.021

    authors: Taylor JH,Asabere N,Calkins ME,Moore TM,Tang SX,Xavier RM,Merikangas AK,Wolf DH,Almasy L,Gur RC,Gur RE

    更新日期:2020-02-01 00:00:00

  • Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.

    abstract:BACKGROUND:Second-generation antipsychotics (SGAs) increase the risk of type 2 diabetes. The mechanism is thought to center on drug-induced weight gain, which starts the dysmetabolic cascade of insulin resistance, increased insulin production and pancreatic beta-cell failure. An independent effect of SGAs on insulin se...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.11.016

    authors: Manu P,Correll CU,Wampers M,van Winkel R,Yu W,Shiffeldrim D,Kane JM,De Hert M

    更新日期:2013-02-01 00:00:00

  • Neurological soft signs in psychometrically identified schizotypy.

    abstract::Patients with schizophrenia often exhibit structural brain abnormalities, as well as neurological soft signs (NSS), consistent with its conceptualization as a neurodevelopmental disorder. NSS are mild, presumably nonlocalizing, neurological impairments that are inferred from performance deficits in domains such as sen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.06.018

    authors: Kaczorowski JA,Barrantes-Vidal N,Kwapil TR

    更新日期:2009-12-01 00:00:00

  • The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.

    abstract:BACKGROUND:Many patients with schizophrenia suffer from metabolic symptoms and weight gain in which predispose them to obesity, diabetes, and cardiovascular problems. This trial examines the efficacy and safety of zonisamide on weight and body mass index in patients with schizophrenia being administered with atypical a...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2013.03.021

    authors: Ghanizadeh A,Nikseresht MS,Sahraian A

    更新日期:2013-06-01 00:00:00

  • Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.

    abstract:BACKGROUND:Neuropsychological impairment is common in schizophrenia and psychotic bipolar disorder. It has been hypothesized that the pathways leading to impairment differ between disorders. Cognitive impairment in schizophrenia is believed to result largely from atypical neurodevelopment, whereas bipolar disorder is i...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.10.009

    authors: Menkes MW,Armstrong K,Blackford JU,Heckers S,Woodward ND

    更新日期:2019-04-01 00:00:00

  • Structural disruption of the dorsal cingulum bundle is associated with impaired Stroop performance in patients with schizophrenia.

    abstract::Previous diffusion tensor imaging (DTI) studies have shown structural abnormalities of the cingulum bundle (CB) in patients with schizophrenia. However, regional specificity and functional relevance of the pregenual and dorsal CB subdivisions has not been fully studied. In the current study, 31 patients with schizophr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.05.012

    authors: Takei K,Yamasue H,Abe O,Yamada H,Inoue H,Suga M,Muroi M,Sasaki H,Aoki S,Kasai K

    更新日期:2009-10-01 00:00:00

  • Childhood laterality and adult schizophrenia spectrum disorders: a prospective investigation.

    abstract::Left or mixed-handedness, footedness, and eye dominance are thought to indicate abnormalities in lateralization related to schizophrenia. Increased left or mixed-dominance in schizophrenia suggests possible hemispheric abnormalities associated with the disorder. A related body of research suggests that some indication...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2004.04.003

    authors: Schiffman J,Pestle S,Mednick S,Ekstrom M,Sorensen H,Mednick S

    更新日期:2005-01-01 00:00:00

  • Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders.

    abstract:BACKGROUND:Patients with schizophrenia and comorbid drug use disorders (DUD) have a severe course of illness. Despite strong evidence that drug use can exacerbate psychotic symptoms, we have limited knowledge of how specific drugs may increase risk of schizophrenia readmission in this group. This study aimed to assess ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.09.026

    authors: Rømer Thomsen K,Thylstrup B,Pedersen MM,Pedersen MU,Simonsen E,Hesse M

    更新日期:2018-05-01 00:00:00

  • Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia.

    abstract:OBJECTIVES:Vesicular glutamate transporters (VGLUT1-3) package glutamate into vesicles in the presynaptic terminal and regulate the release of glutamate. In mesencephalic dopamine neuron culture, the majority of isolated dopamine neurons express VGLUT2, but not VGLUT1 or 3, have been demonstrated. As related to the dys...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.05.015

    authors: Shen YC,Liao DL,Lu CL,Chen JY,Liou YJ,Chen TT,Chen CH

    更新日期:2010-08-01 00:00:00

  • Minor physical anomalies across ethnic groups in a first episode psychosis sample.

    abstract::Minor physical anomalies (MPAs) are more prevalent amongst individuals with psychosis, supporting a neurodevelopmental model for psychotic disorders. The aim of this study was to investigate the possibility that neurodevelopmental adversity contributes to the excess of psychosis found in some ethnic groups in the UK. ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.08.019

    authors: Dean K,Dazzan P,Lloyd T,Morgan C,Morgan K,Doody GA,Hutchinson G,Orr K,Jones PB,Murray RM,Fearon P

    更新日期:2007-01-01 00:00:00

  • Subjective wellbeing under quetiapine treatment: effect of diagnosis, mood state, and anxiety.

    abstract:OBJECTIVE:To examine the effect of diagnosis, mood state, and anxiety on subjective wellbeing in patients with affective and non-affective psychotic disorders treated with quetiapine IR. METHODS:2175 patients with schizophrenia-spectrum (SZ, n=1681), schizoaffective (SA, n=249), and bipolar disorder (BPD, n=245) were ...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.schres.2009.03.004

    authors: Lambert M,Naber D,Karow A,Huber CG,Köhler J,Heymann J,Schimmelmann BG

    更新日期:2009-05-01 00:00:00

  • Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity.

    abstract::Diffusion Tensor Imaging (DTI) investigations in schizophrenia have provided evidence of impairment in white matter as indicated by reduced fractional anisotropy (FA). However, the neuropathological implications of these findings remain unclear. In the current study, we conducted a voxelwise analysis of the constituen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.12.489

    authors: Seal ML,Yücel M,Fornito A,Wood SJ,Harrison BJ,Walterfang M,Pell GS,Pantelis C

    更新日期:2008-04-01 00:00:00

  • Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

    abstract::Schizophrenia (SZ) is a mental illness characterized by psychosis, negative symptoms, and cognitive deficits. The anterior cingulate cortex (ACC), a structurally and functionally diverse region, is one of several brain regions that is abnormal in SZ. The present study compared synaptic organization and mitochondrial n...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.07.016

    authors: Roberts RC,Barksdale KA,Roche JK,Lahti AC

    更新日期:2015-10-01 00:00:00

  • Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.

    abstract::Disrupted-in-Schizophrenia 1 (DISC1), a strong candidate gene for schizophrenia and other mental disorders, regulates neurodevelopmental processes including neurogenesis, neuronal migration, neurite outgrowth and spine development. Glycogen synthase kinase-3 (GSK3) directly interacts with DISC1 and also plays a role i...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.03.032

    authors: Lee FH,Kaidanovich-Beilin O,Roder JC,Woodgett JR,Wong AH

    更新日期:2011-06-01 00:00:00

  • Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia.

    abstract:OBJECTIVES:Recent reports of antibodies to heat shock proteins 60kDa (HSP60) and HSP70 suggested that antibodies to the heat shock protein that plays a protective role against environmental stresses in a cell might be related to the pathogenesis of schizophrenia, although the antibody to HSP90 had not yet been identifi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00091-8

    authors: Kim JJ,Lee SJ,Toh KY,Lee CU,Lee C,Paik IH

    更新日期:2001-10-01 00:00:00

  • Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

    abstract::Autoimmunity, gastrointestinal (GI) disorders and schizophrenia have been associated with one another for a long time. This paper reviews these connections and provides a context by which multiple risk factors for schizophrenia may be related. Epidemiological studies strongly link schizophrenia with autoimmune disorde...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2014.06.027

    authors: Severance EG,Yolken RH,Eaton WW

    更新日期:2016-09-01 00:00:00

  • Specific cognitive deficits and differential domains of social functioning impairment in schizophrenia.

    abstract::There is considerable inconsistency in findings regarding the relationship between specific cognitive deficits and social impairment in patients with schizophrenia. This inconsistency may relate to variability across studies in how social functioning is measured and preliminary evidence suggests that different indices...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.09.007

    authors: Cohen AS,Forbes CB,Mann MC,Blanchard JJ

    更新日期:2006-01-31 00:00:00

  • Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?

    abstract:OBJECTIVE:Studies in first episode psychosis samples about status of cardiovascular risk factors have shown discordant results. We aimed to determine the 10-year risk of developing coronary heart disease in a sample of first episode psychosis patients referred to an early intervention clinic and compared the same with ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.12.008

    authors: Phutane VH,Tek C,Chwastiak L,Ratliff JC,Ozyuksel B,Woods SW,Srihari VH

    更新日期:2011-04-01 00:00:00